-
November 4, 2021 Why We’re Excited About Compass Pathways’ New Clinical Trial Treating PTSD with PsilocybinCompass Pathways (Nasdaq: CMPS) has announced the launch of a brand new psychedelic clinical trial,...
-
October 13, 2021 Why Psychedelic Stocks Have Crashed in the Last 3 MonthsOur resident psychedelic investor explains why psychedelic stocks are plummeting, and why patience can pay...
-
September 17, 2021 Psychedelic Business Spotlight: September 17, 2021This week in psychedelic business news: Wesana teams up with MAPS, MindBio Therapeutics announces world-class...
-
July 9, 2021 Psychedelic Business Spotlight: July 9, 2021This week in psychedelic business news: It’s all about partnerships and acquisitions designed to advance...
